Annovis Bio Inc. (ANVS) option IV into data

Annovis Bio Inc. (NYSE: ANVS) 30-day option implied volatility is at 333; compared to its 52-week range of 21 to 333 into topline efficacy data for phase II/III study of buntanetap in patients with mild to moderate Alzheimer's disease is expected in April.

You May Also Be Interested In

• Robinhood (HOOD) calls more active than puts into quarter results
• Seagate Technology (STX) call put ratio 1 call to 1.5 puts into quarter results
• Meta Platforms (META) call put ratio 1.6 calls to 1 put with a focus on July 31 weekly 592.50 calls into quarter results